We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Goals for Unsolicited Amendments Dominate Recent User Fee Meeting
Goals for Unsolicited Amendments Dominate Recent User Fee Meeting
July 19, 2011
The generic-drug industry and the FDA have agreed to a three-tier system of review goals for ANDA amendments under the new generic-drug user fee program now under negotiation.